Clinical Trial Update: Sequential Combination Therapy With PD-1 Antibody and Peg-IFNα in CHB Patients [NA]

View source ↗

Summary

A clinical trial evaluating sequential therapy with a PD-1 antibody followed by Peg-IFNα in chronic hepatitis B patients; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• PD-1 antibody (PD-1 inhibitor)
• Pegylated interferon alfa (pegylated interferon alfa)

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Chronic Hepatitis B | NA | Status: RECRUITING